Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India

Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India

Background: Single dose of Nevirapine to prevent mother to child transmission of HIV is the commonest preventive regimen in resource-limited countries. Objectives: The objective of this study was to detect drug-resistant virus after single dose of Nevirapine (sdNVP) provided to delivering HIV seropo...

Full description

Bibliographic Details
Main Authors:	Mini S Jacob, Anitha Durairaj, James Vijayakumari, Parameshwari Srijayanth, M R Sivakumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2011-01-01
Series:	Indian Journal of Pathology and Microbiology
Subjects:	HIV mutations Nevirapine oligonucleotide ligation assay
Online Access:	http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=2;spage=359;epage=361;aulast=Jacob

Similar Items

Rapid Determination of Nevirapine in Human Plasma by High- Performance Liquid Chromatography
by: Kantima Sangsiriwut, et al.
Published: (2007-01-01)

Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital
by: William Kondo, et al.

Perbandingan Penggunaan Efavirenz dan Nevirapine Terhadap Kolesterol LDL Pasien HIV/AIDS
by: Anggriani Yusi, et al.
Published: (2019-08-01)

Proportion of HIV exposed infants aged 0-6 months that missed nevirapine prophylaxis in Mulago National Referral Hospital, Uganda: a cross-sectional study
by: Nasambu Hellen, et al.
Published: (2024-07-01)

Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India
by: Ram Malathi, et al.
Published: (2012-10-01)

Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
by: Julia Notter, et al.
Published: (2019-04-01)

Combined antiretroviral therapy with nevirapine of HIV-infected adults
by: A V Kravchenko
Published: (2004-11-01)

The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment
by: Sinha Sanjeev, et al.
Published: (2011-11-01)

Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals
by: Prabhakar Panzade, et al.
Published: (2021-09-01)

Time series analysis of Nevirapine syrup consumption in prevention of mother-tochild transmission and optimal supply chain model in Oshana region, Namibia
by: Emmanuel Magesa, et al.
Published: (2020-04-01)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01)

Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study
by: Bih Hycenta Chendi, et al.
Published: (2019-02-01)

Oxidation of 2-Hydroxynevirapine, a Phenolic Metabolite of the Anti-HIV Drug Nevirapine: Evidence for an Unusual Pyridine Ring Contraction
by: Frederick A. Beland, et al.
Published: (2012-03-01)

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
by: Andrea Giacomelli, et al.
Published: (2018-11-01)

Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase
by: Yan Wang, et al.
Published: (2022-10-01)

Factors associated with stockout of Nevirapine syrup in Oshana Region, Namibia
by: Emmanuel Magesa, et al.
Published: (2020-03-01)

Avaliação dos efeitos colaterais da nevirapina em gestantes HIV positivo em Hospital Universitário do sul do Brasil Evaluation of the adverse effects of nevirapine in HIV-infected pregnant women in a South Brazilian University Hospital
by: William Kondo, et al.
Published: (2008-01-01)

The Distinction in Level of Stress, Anxiety, and Depression between Efavirenz with Nevirapine Therapies (Study on HIV/AIDS-infected patients at VCT-CST clinic Dr.Kariadi Hospital Semarang)
by: Muflihatunnaimah Muflihatunnaimah, et al.
Published: (2018-06-01)

Nevirapine-induced Stevens-Johnson syndrome in children living with HIV in South Africa
by: Jacques D. du Toit, et al.
Published: (2021-02-01)

Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan
by: Chun-Yuan Lee, et al.
Published: (2017-04-01)

Possible hepatotoxic consequence of nevirapine use in juvenile albino rats
by: Elias Adikwu, et al.
Published: (2017-08-01)

Nevirapine-Induced Stevens–Johnson Syndrome in an HIV-Infected Patient: A Case Report From Uganda
by: Jayte M, et al.
Published: (2025-02-01)

Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
by: Tin Tin Sint, et al.

Cost-effectiveness of childbirth strategies for prevention of mother-to-child transmission of HIV among mothers receiving nevirapine in India
by: Mukherjee Kanchan
Published: (2010-01-01)

Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir
by: Ingrid A. Beck, et al.
Published: (2024-07-01)

Green HPLC quantification method of lamivudine, zidovudine and nevirapine with identification of related substances in tablets
by: Ludivine Vieira-Sellaï, et al.
Published: (2022-07-01)

Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up
by: Juan Tiraboschi, et al.
Published: (2019-11-01)

AMELIORATIVE EFFECTS OF VITAMINS C AND E ON TENOFOVIR/NEVIRAPINE-INDUCED HEPATORENAL OXIDATIVE STRESS IN ALBINO RATS
by: Elias Adikwu, et al.
Published: (2016-10-01)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
by: Sanjeev Sinha, et al.
Published: (2017-12-01)

Studies on some neuropharmacological properties of Nevirapine in mice
by: Peter Uchogu Ahmadu, et al.
Published: (2022-06-01)

Dosage Optimization of Treatments Using Population Pharmacokinetic Modeling and Simulation
by: M. Guidi, et al.
Published: (2012-05-01)

Highly Efficient Chemoprophylaxis of Perinatal Transmission of HIV 1 Infection in HIV-Infected Pregnant Women
by: G. A. Galegov
Published: (2020-05-01)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
by: Kate Shearer, et al.
Published: (2014-01-01)

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
by: M. Matilde Marques, et al.
Published: (2013-04-01)

Nevirapine induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human Immunodeficiency Virus positive patient
by: Leelavathy Budamakuntla, et al.
Published: (2014-01-01)

Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
by: Hongxia Shang, et al.
Published: (2019-12-01)

Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting
by: Faithful Makita-Chingombe, et al.
Published: (2019-05-01)

Efficacy of Mobile phone use on adherence to Nevirapine prophylaxis and retention in care among the HIV-exposed infants in prevention of mother to child transmission of HIV: a randomized controlled trial
by: Lilian M. N. Kebaya, et al.
Published: (2021-04-01)

Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine
by: Siripassorn Krittaecho, et al.
Published: (2013-01-01)

Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-Trial)
by: Weberschock T, et al.
Published: (2009-12-01)